Spinal Implants | Market Insights | US | 2022
The COVID-19 pandemic has significantly impacted the US spinal implant market because regional restrictions on elective procedures resulted in delays to degenerative and deformity spine procedures and declining unit sales. Resurging cases at the end of 2020 resulting in new restrictions have impacted procedures into 2021. Recovery of the market will depend on a number of factors, including the ability of facilities to return to prepandemic capacity and the pace of vaccine distribution in the US. Although the crisis has significantly impacted the market in the short-term, other factors will continue to drive market growth over the forecast period. In particular, spinal implant market expansion will be driven by the uptake of premium innovations such as 3-D printed implants, nonfusion technologies, and minimally invasive devices. Nonetheless, downward pricing pressure resulting from hospital budget constraints, procedure volumes shifting toward ASCs, and implant commoditization will limit overall market potential, even as favorable demographic trends support modest procedure volume growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for spinal implants in the US across an 11-year period.
